항비만제 시장은 2024년부터 2029년까지 229억 530만 달러 증가하고, 예측 기간 동안 15.7%의 CAGR로 성장할 것으로 예상됩니다.
항비만제 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 포함한 벤더 분석 등의 정보를 전해드립니다.
현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 비만 인구의 증가, 병적 비만에 대한 제한적인 비만 수술의 사용, 제한된 수의 승인된 약물에 의해 주도되고 있습니다.
| 시장 범위 |
| 기준 연도 |
2025년 |
| 종료 연도 |
2029년 |
| 예측 기간 |
2025-2029년 |
| 성장 모멘텀 |
가속 |
| 전년 대비 2025년 |
13.2% |
| CAGR |
15.7% |
| 증가액 |
229억 530만 달러 |
이 조사는 업계 주요 참가자의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 보고서에는 주요 기업 분석, 종합적인 시장 규모 데이터, 지역 분석에 따른 세분화, 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 있습니다.
본 조사에서는 향후 몇 년간 항비만제 시장 성장을 견인할 주요 요인 중 하나로 비만과 제2형 당뇨병을 동시에 치료할 수 있는 약물에 대한 조사를 꼽았습니다. 또한, 체중 관리에 대한 인식, 소아 비만 및 병적 비만 발생률의 증가는 시장의 큰 수요로 이어질 것입니다.
목차
제1장 주요 요약
제2장 Technavio 분석
- 가격·수명주기·고객 구입 바스켓·채용률·구입 기준 분석
- 인풋의 중요성과 차별화 요인
- 혼란 요인
- 성장 촉진요인과 과제의 영향
제3장 시장 상황
제4장 시장 규모
- 시장 정의
- 시장 부문 분석
- 시장 규모 2024년
- 시장 전망 2024-2029년
제5장 시장 규모 실적
- 항비만제 세계 시장 2019-2023년
- 유형별 부문 분석 2019-2023년
- 약물 클래스별 부문 분석 2019-2023년
- 유통 채널별 부문 분석 2019-2023년
- 투여 경로별 부문 분석 2019-2023년
- 지역별 부문 분석 2019-2023년
- 국가별 부문 분석 2019-2023년
제6장 정성 분석
제7장 Five Forces 분석
- Five Forces 요약
- 구매자의 교섭력
- 공급 기업의 교섭력
- 신규 참여업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 상황
제8장 시장 세분화 : 유형별
- 시장 부문
- 비교 : 유형별
- 클래스 III : 시장 규모와 예측 2024-2029년
- 클래스 II 항비만제 : 시장 규모와 예측 2024-2029년
- 클래스 I 항비만제 : 시장 규모와 예측 2024-2029년
- 시장 기회 : 유형별
제9장 시장 세분화 : 약물 종류별
- 시장 부문
- 비교 : 약물 종류별
- 말초 작용약 : 시장 규모와 예측 2024-2029년
- 중추 작용약 : 시장 규모와 예측 2024-2029년
- 시장 기회 : 약물 종류별
제10장 시장 세분화 : 유통 채널별
- 시장 부문
- 비교 : 유통 채널별
- 병원 약국 : 시장 규모와 예측 2024-2029년
- 소매 약국 : 시장 규모와 예측 2024-2029년
- 드럭스토어 : 시장 규모와 예측 2024-2029년
- E-Commerce : 시장 규모와 예측 2024-2029년
- 시장 기회 : 유통 채널별
제11장 시장 세분화 : 투여 경로별
- 시장 부문
- 비교 : 투여 경로별
- 경구 투여 : 시장 규모와 예측 2024-2029년
- 피하 투여 : 시장 규모와 예측 2024-2029년
- 시장 기회 : 투여 경로별
제12장 고객 상황
제13장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측 2024-2029년
- 유럽 : 시장 규모와 예측 2024-2029년
- 아시아 : 시장 규모와 예측 2024-2029년
- 세계 기타 지역 : 시장 규모와 예측 2024-2029년
- 미국 : 시장 규모와 예측 2024-2029년
- 캐나다 : 시장 규모와 예측 2024-2029년
- 독일 : 시장 규모와 예측 2024-2029년
- 영국 : 시장 규모와 예측 2024-2029년
- 프랑스 : 시장 규모와 예측 2024-2029년
- 중국 : 시장 규모와 예측 2024-2029년
- 이탈리아 : 시장 규모와 예측 2024-2029년
- 멕시코 : 시장 규모와 예측 2024-2029년
- 브라질 : 시장 규모와 예측 2024-2029년
- 일본 : 시장 규모와 예측 2024-2029년
- 시장 기회 : 지역 상황별
제14장 촉진요인, 과제, 기회, 억제요인
- 시장 성장 촉진요인
- 시장 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회·억제요인
제15장 경쟁 구도
제16장 경쟁 분석
- 기업 개요
- 기업 순위 지수
- 기업의 시장 포지셔닝
- Alvogen Inc
- AstraZeneca Plc
- Boehringer Ingelheim International GmbH
- Eli Lilly and Co.
- Empros Pharma AB
- ERX Pharmaceuticals Inc.
- Gelesis Inc.
- GlaxoSmithKline Plc
- Innovent Biologics Inc.
- LG Chem Ltd.
- Novo Nordisk AS
- Rhythm Pharmaceuticals Inc.
- SCOHIA PHARMA Inc.
- VIVUS LLC
- Zydus Lifesciences Ltd.
제17장 부록
ksm
The anti-obesity drugs market is forecasted to grow by USD 22905.3 million during 2024-2029, accelerating at a CAGR of 15.7% during the forecast period. The report on the anti-obesity drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing obese population, use of bariatric surgery limited for morbid obesity, and limited number of approved drugs.
| Market Scope |
|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 13.2% |
| CAGR | 15.7% |
| Incremental Value | $22905.3 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's anti-obesity drugs market is segmented as below:
By Type
- Class III
- Class II anti-obesity drugs
- Class I anti-obesity drugs
By Drug Class
- Peripherally acting drugs
- Centrally acting drugs
By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Drug stores
- E-commerce
By Route Of Administration
- Oral route
- Subcutaneous route
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the research on drugs that target both obesity and type 2 diabetes mellitus as one of the prime reasons driving the anti-obesity drugs market growth during the next few years. Also, awareness about weight management and increase in childhood obesity and morbid obesity incidence will lead to sizable demand in the market.
The report on the anti-obesity drugs market covers the following areas:
- Anti-Obesity Drugs Market sizing
- Anti-Obesity Drugs Market forecast
- Anti-Obesity Drugs Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anti-obesity drugs market vendors that include Alvogen Inc, Amgen Inc., AstraZeneca PLC, Boehringer Ingelheim International GmbH, Eli Lilly and Co., Empros Pharma AB, ERX Pharmaceuticals Inc., Gelesis Inc., GlaxoSmithKline PLC, Innovent Biologics Inc., LG Chem Ltd., Novo Nordisk AS, Rhythm Pharmaceuticals Inc., SCOHIA PHARMA Inc., VIVUS LLC, and Zydus Lifesciences Ltd.. Also, the anti-obesity drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Anti-Obesity Drugs Market 2019 - 2023
- Historic Market Size - Data Table on Global Anti-Obesity Drugs Market 2019 - 2023 ($ million)
- 5.2 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
- 5.3 Drug Class segment analysis 2019 - 2023
- Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
- 5.4 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
- 5.5 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
- 5.6 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.7 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Anti-obesity Drugs Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
- 8.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- 8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 8.3 Class III - Market size and forecast 2024-2029
- Chart on Class III - Market size and forecast 2024-2029 ($ million)
- Data Table on Class III - Market size and forecast 2024-2029 ($ million)
- Chart on Class III - Year-over-year growth 2024-2029 (%)
- Data Table on Class III - Year-over-year growth 2024-2029 (%)
- 8.4 Class II anti-obesity drugs - Market size and forecast 2024-2029
- Chart on Class II anti-obesity drugs - Market size and forecast 2024-2029 ($ million)
- Data Table on Class II anti-obesity drugs - Market size and forecast 2024-2029 ($ million)
- Chart on Class II anti-obesity drugs - Year-over-year growth 2024-2029 (%)
- Data Table on Class II anti-obesity drugs - Year-over-year growth 2024-2029 (%)
- 8.5 Class I anti-obesity drugs - Market size and forecast 2024-2029
- Chart on Class I anti-obesity drugs - Market size and forecast 2024-2029 ($ million)
- Data Table on Class I anti-obesity drugs - Market size and forecast 2024-2029 ($ million)
- Chart on Class I anti-obesity drugs - Year-over-year growth 2024-2029 (%)
- Data Table on Class I anti-obesity drugs - Year-over-year growth 2024-2029 (%)
- 8.6 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Drug Class
- 9.1 Market segments
- Chart on Drug Class - Market share 2024-2029 (%)
- Data Table on Drug Class - Market share 2024-2029 (%)
- 9.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- 9.3 Peripherally acting drugs - Market size and forecast 2024-2029
- Chart on Peripherally acting drugs - Market size and forecast 2024-2029 ($ million)
- Data Table on Peripherally acting drugs - Market size and forecast 2024-2029 ($ million)
- Chart on Peripherally acting drugs - Year-over-year growth 2024-2029 (%)
- Data Table on Peripherally acting drugs - Year-over-year growth 2024-2029 (%)
- 9.4 Centrally acting drugs - Market size and forecast 2024-2029
- Chart on Centrally acting drugs - Market size and forecast 2024-2029 ($ million)
- Data Table on Centrally acting drugs - Market size and forecast 2024-2029 ($ million)
- Chart on Centrally acting drugs - Year-over-year growth 2024-2029 (%)
- Data Table on Centrally acting drugs - Year-over-year growth 2024-2029 (%)
- 9.5 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
10 Market Segmentation by Distribution Channel
- 10.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
- 10.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- 10.3 Hospital pharmacies - Market size and forecast 2024-2029
- Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
- 10.4 Retail pharmacies - Market size and forecast 2024-2029
- Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
- 10.5 Drug stores - Market size and forecast 2024-2029
- Chart on Drug stores - Market size and forecast 2024-2029 ($ million)
- Data Table on Drug stores - Market size and forecast 2024-2029 ($ million)
- Chart on Drug stores - Year-over-year growth 2024-2029 (%)
- Data Table on Drug stores - Year-over-year growth 2024-2029 (%)
- 10.6 E-commerce - Market size and forecast 2024-2029
- Chart on E-commerce - Market size and forecast 2024-2029 ($ million)
- Data Table on E-commerce - Market size and forecast 2024-2029 ($ million)
- Chart on E-commerce - Year-over-year growth 2024-2029 (%)
- Data Table on E-commerce - Year-over-year growth 2024-2029 (%)
- 10.7 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
11 Market Segmentation by Route of Administration
- 11.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
- 11.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- 11.3 Oral route - Market size and forecast 2024-2029
- Chart on Oral route - Market size and forecast 2024-2029 ($ million)
- Data Table on Oral route - Market size and forecast 2024-2029 ($ million)
- Chart on Oral route - Year-over-year growth 2024-2029 (%)
- Data Table on Oral route - Year-over-year growth 2024-2029 (%)
- 11.4 Subcutaneous route - Market size and forecast 2024-2029
- Chart on Subcutaneous route - Market size and forecast 2024-2029 ($ million)
- Data Table on Subcutaneous route - Market size and forecast 2024-2029 ($ million)
- Chart on Subcutaneous route - Year-over-year growth 2024-2029 (%)
- Data Table on Subcutaneous route - Year-over-year growth 2024-2029 (%)
- 11.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
12 Customer Landscape
- 12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
- 13.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
- 13.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 13.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 13.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 13.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 13.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 13.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 13.8 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 13.9 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 13.10 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 13.11 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 13.12 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 13.13 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 13.14 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- 13.15 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 13.16 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 13.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
14 Drivers, Challenges, and Opportunity/Restraints
- 14.1 Market drivers
- 14.2 Market challenges
- 14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 14.4 Market opportunities/restraints
15 Competitive Landscape
- 15.1 Overview
- 15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 15.3 Landscape disruption
- Overview on factors of disruption
- 15.4 Industry risks
- Impact of key risks on business
16 Competitive Analysis
- 16.1 Companies profiled
- 16.2 Company ranking index
- 16.3 Market positioning of companies
- Matrix on companies position and classification
- 16.4 Alvogen Inc
- Alvogen Inc - Overview
- Alvogen Inc - Product / Service
- Alvogen Inc - Key offerings
- SWOT
- 16.5 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
- 16.6 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
- SWOT
- 16.7 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
- 16.8 Empros Pharma AB
- Empros Pharma AB - Overview
- Empros Pharma AB - Product / Service
- Empros Pharma AB - Key offerings
- SWOT
- 16.9 ERX Pharmaceuticals Inc.
- ERX Pharmaceuticals Inc. - Overview
- ERX Pharmaceuticals Inc. - Product / Service
- ERX Pharmaceuticals Inc. - Key offerings
- SWOT
- 16.10 Gelesis Inc.
- Gelesis Inc. - Overview
- Gelesis Inc. - Product / Service
- Gelesis Inc. - Key offerings
- SWOT
- 16.11 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- 16.12 Innovent Biologics Inc.
- Innovent Biologics Inc. - Overview
- Innovent Biologics Inc. - Product / Service
- Innovent Biologics Inc. - Key offerings
- SWOT
- 16.13 LG Chem Ltd.
- LG Chem Ltd. - Overview
- LG Chem Ltd. - Business segments
- LG Chem Ltd. - Key news
- LG Chem Ltd. - Key offerings
- LG Chem Ltd. - Segment focus
- SWOT
- 16.14 Novo Nordisk AS
- Novo Nordisk AS - Overview
- Novo Nordisk AS - Business segments
- Novo Nordisk AS - Key offerings
- Novo Nordisk AS - Segment focus
- SWOT
- 16.15 Rhythm Pharmaceuticals Inc.
- Rhythm Pharmaceuticals Inc. - Overview
- Rhythm Pharmaceuticals Inc. - Product / Service
- Rhythm Pharmaceuticals Inc. - Key news
- Rhythm Pharmaceuticals Inc. - Key offerings
- SWOT
- 16.16 SCOHIA PHARMA Inc.
- SCOHIA PHARMA Inc. - Overview
- SCOHIA PHARMA Inc. - Product / Service
- SCOHIA PHARMA Inc. - Key news
- SCOHIA PHARMA Inc. - Key offerings
- SWOT
- 16.17 VIVUS LLC
- VIVUS LLC - Overview
- VIVUS LLC - Product / Service
- VIVUS LLC - Key offerings
- SWOT
- 16.18 Zydus Lifesciences Ltd.
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus
- SWOT
17 Appendix
- 17.1 Scope of the report
- 17.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 17.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 17.4 Research methodology
- 17.5 Data procurement
- 17.6 Data validation
- 17.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 17.8 Data synthesis
- 17.9 360 degree market analysis
- 360 degree market analysis
- 17.10 List of abbreviations
